Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
The Next Generation of Therapies for Type 2 Diabetes
Course Director
Charles Faiman, MD, FRCPC, MACE
Consultant and Past Chairman
Department of Endocrinology, Diabetes and Metabolism
Cleveland Clinic
Cleveland, Ohio
Faculty
Lawrence Blonde, MD, FACP, FACE
Director, Ochsner Diabetes Clinical Research Unit
Department of Endocrinology, Diabetes and Metabolism
Associate Internal Medicine Residency Program Director
Ochsner Medical Center
New Orleans, LA
Accredited by
Cleveland Clinic Center for Continuing Education
View Activity Materials
Course Description
Learning Objectives
1. Discuss unmet needs with conventional therapies for Interpret clinical trial data of recently approved and emerging incretin-related therapies.
2. Compare and contrast dosing and outcomes with insulin glargine and an ultra-long-acting basal insulin.
3. Review the rationale for SGLT-2 inhibitor treatment and data with investigational SGLT-2 inhibitors.
Activity Details
| Credit Types: | CME |
| Credit Amount: | 0.75 Credits |
| Release Date: | 2011-Dec-27 |
| Expiration Date: | 2012-Dec-27 |
| Estimated Time for Completion: | 45 minutes |
| Registration Required: | No |
| Cost: | Free |
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
